SP

Sudhir Pandey

Active Director Director DIN 09420938
DIN 09420938 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Sudhir Pandey

Data last updated:

Sudhir Pandey is a Director at Skele Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Skele Pharmaceuticals Private Limited reported revenue of ₹7.1 Lakh (FY 2023).

DIN 09420938
Primary Designation Director
Industry Chemicals
First Appointment 01 Dec 2021
Oldest Company Age 4 yrs
Largest company Skele Pharmaceuticals Private Limited · ₹7.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20212021₹7.1 Lakh (FY 2023)Active

Board colleagues of Sudhir Pandey

NameDINCompanyDesignation
Devi Shankar09420939Skele Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Skele Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sudhir Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Pandey

Sudhir Pandey currently holds 1 directorship: Skele Pharmaceuticals Private Limited (Director, since 01 Dec 2021, revenue ₹7.1 Lakh (FY 2023)).

Sudhir Pandey was first appointed on 01 Dec 2021 as Director at Skele Pharmaceuticals Private Limited.

The current boards of Sudhir Pandey's companies include Devi Shankar (Skele Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available